Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Bajaj Finserv Healthcare Fund (G) Direct |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
6.89 |
Equity |
91.83 |
Trep |
1.28 |
|
|
Concentration Analysis |
Top 5 Holdings |
39.91% |
Top 10 Holdings |
59.95% |
Top 25 Holdings |
88.49% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
69.39 |
Healthcare |
13.01 |
Cash |
8.17 |
FMCG |
3.8 |
Agricultural & Farm Machinery |
1.18 |
Insurance |
1.06 |
Consumer Non Durable |
1.05 |
SERVICES |
0.95 |
Industrial Products |
0.5 |
Chemicals |
0.47 |
Food Beverage & Tobacco |
0.42 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.56 |
PE Ratio |
42.43 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
DIVI LABORATORIES LTD |
8.74 |
Sun Pharmaceutical Industries Limited |
8.65 |
Dr Reddys Laboratories Limited |
8.46 |
Cipla Limited |
7.17 |
Net Receivables / (Payables) |
6.89 |
Apollo Hospitals Enterprise Limited |
5.28 |
Biocon Limited |
4.24 |
Piramal Pharma Limited |
3.98 |
Neuland Laboratories Limited |
3.29 |
Syngene International Limited |
3.25 |
Orchid Pharma Limited |
3.12 |
Emcure Pharmaceuticals Limited |
2.85 |
Torrent Pharmaceuticals Limited |
2.56 |
Hindustan Unilever Limited |
2.33 |
IPCA Laboratories Limited |
2.13 |
SANOFI CONSUMER HEALTHCARE |
1.97 |
Glenmark Pharmaceuticals Limited |
1.94 |
Rainbow Childrens Medicare Limited |
1.73 |
Abbott India Limited |
1.70 |
Alkem Laboratories Limited |
1.48 |
Emami Limited |
1.47 |
Vijaya Diagnostic Centre Limited |
1.46 |
Dr Lal Path Labs Ltd |
1.29 |
Clearing Corporation of India Ltd |
1.28 |
Lupin Limited |
1.23 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|